CureClick
THREAD, a US-based clinical research technology company, sells a no-code decentralized clinical trial platform unifying 12 trial technologies with consultative patient-centered outcomes research and patient-voice services for pharmaceutical, biotechnology, and CRO customers globally.
- Company typePrivate
- Founded2014
- HeadquartersCosta Mesa, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What CureClick does
THREAD, operated by Definitive Media Corp, is a US-based clinical research technology company that sells a no-code decentralized clinical trial (DCT) platform to pharmaceutical, biotechnology, and contract research organization (CRO) sponsors across the United States, the United Kingdom, Germany, France, Spain, and Italy. The platform consolidates twelve clinical trial technologies—eCOA and eDiaries, eConsent, telehealth virtual visits, voice/image/video capture, digital health technology sensors, eCRFs and eSource, engagement and retention, SSO, APIs and integrations, configurable data reporting, real-time analytics, and global cloud—into a single configurable system that supports site-based, hybrid, and fully decentralized study designs. The company bundles a scientific services arm around the software, most notably the Modus Outcomes patient-centered outcomes research (PCOR) team for endpoint selection and validation, and a Patient and HCP Listening capability powered by inVibe technology for systematic capture of patient and clinician voice.
The business operates on a two-stream revenue model: subscription-based access to the THREAD clinical trial platform and professional services revenue from consultative engagements including study design and operational support. Go-to-market is direct enterprise field sales with a consultative selling motion; pricing is quote-based rather than publicly disclosed, and the company uses 'Request a Demo' and 'Schedule a Quick Demo' as primary conversion paths. The platform is deployed on AWS global cloud infrastructure and is transactable via the AWS Marketplace, and it carries an enterprise-grade compliance stack including SOC 2 Type II, ISO 27001, GDPR, HIPAA, and FDA 21 CFR Part 11, complemented by the 2025 Digital Medicine Society (DiMe) Seal for Quality and Trust and an EcoVadis sustainability medal. THREAD sells horizontally across research types (digital health technology, MedTech, pediatrics, registries, Phase 2/3, Phase 3b/4 post-approval) and purposefully across therapeutic areas including cardiovascular and metabolic, dermatology, neurology and CNS, oncology, rare disease, cell and gene therapy, gastroenterology, hematology, immunology and rheumatology, infectious diseases, obesity and diabetes, ophthalmology, and pulmonology.
CureClick firmographics
Firmographics- Name
- CureClick
- Legal name
- Definitive Media Corp dba THREAD
- Website
- https://cureclick.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- THREAD, a US-based clinical research technology company, sells a no-code decentralized clinical trial platform unifying 12 trial technologies with consultative patient-centered outcomes research and patient-voice services for pharmaceutical, biotechnology, and CRO customers globally.
- Ownership category
- akta.pro rank
CureClick industry classification
Industry- Product category
- Decentralized Clinical Trial Platform
- NAICS
- Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)
Keywords
Where CureClick is headquartered
LocationHeadquarters
- HQ city
- Costa Mesa
- HQ country
- United States
- HQ region
- North America
Markets served
CureClick business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Clinical Research Technology Platform: Subscription-based access to THREAD's no-code clinical research platform including 12 clinical trial technologies. The platform is offered as a comprehensive solution for study sponsors and CROs.
- Consultative Services: Expert consulting services including study design, endpoint selection, patient-centered outcomes research (PCOR), and enablement services (Define and Support).
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
CureClick product offering
Product offeringCore offering
CureClick operates a no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth, eCRFs, voice/image/video capture, digital health technology, real-time analytics) into a single unified system. The platform is paired with consultative services including patient-centered outcomes research (PCOR) through Modus Outcomes and enablement services (Define and Support) for life science organizations, CROs, and academic research institutions. The company supports site-based, fully decentralized, or hybrid clinical studies across multiple countries and languages.
Product overview
THREAD is a clinical research technology company offering a unified decentralized clinical trial (DCT) platform combining 12 clinical trial technologies. The platform operates on a modular architecture comprising a No-Code Platform for study configuration, multiple technology modules (eCOA and eDiaries, eConsent, Telehealth Virtual Visits, Voice/Image/Video Capture, Digital Health Technology/Sensors, eCRFs/eSource, Realtime Analytics), access capabilities (API and Integrations, Configurable SSO, Global Cloud, RWD and Tokenization), and consultative services (Modus Outcomes PCOR services, Enablement Services). The platform is powered by AI and integrates with AWS Marketplace for cloud deployment. The company also offers purpose-built solutions across therapeutic areas (Cardiovascular, Dermatology, Neurology/CNS, Oncology, Rare Disease) and research types (Digital Health Technology, MedTech, Pediatrics, Registries, Phase 2/3 Clinical Trials, Phase 3b/4 Post Approval Studies).
Differentiator
Problem solved
Functional benefit
Products and services
- THREAD Platform A comprehensive no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth virtual visits, eCRFs, voice/image/video capture, digital health technology, real-time analytics) for site-based, fully decentralized, or hybrid clinical studies. Built for life science organizations, CROs, and academic research institutions.
- Patient and HCP Listening A solution for engaging patients and healthcare providers in study design through structured listening sessions and co-creation methodologies, powered by inVibe technology. Enables study sponsors and CROs to collect and analyze real patient voices in a simple, systematic, and scalable way across the organization.
- Modus Outcomes (PCOR Services) Patient-centered outcomes research (PCOR) professional services including endpoint selection, validation, and measurement expertise. Provides scientifically validated outcome measures grounded in the patient experience to optimize decision-making about the development, commercialization, and use of medical products.
- Consultative Services (Define and Support) Enablement services offering study design (Define) and operational support throughout the research lifecycle for clinical trial execution, paired with the THREAD platform technology.
Quantifiable outcome
- Reduce research study costs and timelines
- +2 more outcomes
Companies that use CureClick
Customer profileSegments3 records
Ideal customer profiles3 records
CureClick technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature5 records
CureClick partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- AWS (Amazon Web Services)coreAWS Partner with THREAD available on the AWS Marketplace. Platform runs on AWS cloud infrastructure providing global cloud capabilities, scalability, and reliability for clinical trial operations.
- Digital Medicine Society (DiMe)minorDiMe awarded THREAD the DiMe Seal for Quality and Trust, recognizing excellence in digital medicine technology.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
CureClick competitors and assessment
Company assessmentDirect peers
- Medidata (Dassault Systèmes): Medidata's Rave EDC, eCOA, and DCT offerings compete head-to-head with THREAD for the same pharma/biotech and CRO sponsors running decentralized and hybrid studies.
- Medable: Medable is a DCT-native platform offering eCOA, eConsent, telehealth, and remote monitoring — directly overlapping THREAD's modular DCT stack.
- Science 37 (now Evidera/PPD): Science 37 pioneered fully decentralized trial execution and is a direct DCT competitor to THREAD, particularly for sponsor-led direct-to-patient studies.
- Castor: Castor provides a configurable EDC and DCT platform for academic and commercial sponsors, competing with THREAD's no-code configuration layer and eCRF/eSource module.
- Clario (ERT / Bioclinica): Clario is a major eCOA and DCT technology provider serving pharma/biotech, directly overlapping THREAD's eCOA, eDiaries, and endpoint capture capabilities.
- Signant Health: Signant Health provides eCOA, eConsent, and patient engagement solutions for clinical trials — a direct competitor to THREAD's Patient and HCP Listening and eCOA modules.
- YPrime: YPrime offers eCOA, IRT, and DCT-configurable clinical trial technology with a comparable modular platform approach to THREAD's no-code configuration.
Broad incumbents
- Veeva Systems: Veeva's Vault CDB, Vault EDC, and broader clinical suite compete with THREAD as part of a wider enterprise clinical platform targeting large pharma sponsors.
- Oracle Health Sciences (Clinical One / Inform): Oracle's Clinical One and legacy Phase One/Rave-adjacent EDC compete with THREAD for enterprise trial platforms, particularly with large pharma running complex global studies.
- IQVIA: IQVIA combines CRO services with its own DCT and eCOA technology stack, competing with THREAD both as a technology vendor and as a service provider to the same sponsor base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
CureClick social profiles
Digital presenceCureClick compliance and trust
Trust signalCompliance6 records
CureClick financial estimates
Financial estimateRevenue estimate
Valuation estimate
CureClick leadership team
Management profileNumber of profiles
CureClick funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CureClick M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CureClick
What does CureClick do?
CureClick operates a no-code, fully configurable decentralized clinical trial (DCT) platform that consolidates 12 clinical trial technologies (eCOA, eDiaries, eConsent, telehealth, eCRFs, voice/image/video capture, digital health technology, real-time analytics) into a single unified system. The platform is paired with consultative services including patient-centered outcomes research (PCOR) through Modus Outcomes and enablement services (Define and Support) for life science organizations, CROs, and academic research institutions. The company supports site-based, fully decentralized, or hybrid clinical studies across multiple countries and languages.
Is CureClick a public or private company?
CureClick is a private company. It is classified as unknown and is currently operating.
When was CureClick founded?
CureClick was founded in 2014. It employs 1 to 10 people.
Where is CureClick based?
CureClick is headquartered in Costa Mesa, United States, in the North America region.
How does CureClick make money?
Two revenue lines are on record. Clinical Research Technology Platform is the primary driver. The others are consultative Services.
Who are CureClick's main competitors?
Direct peers on record are Medidata (Dassault Systèmes), Medable, Science 37 (now Evidera/PPD), Castor, Clario (ERT / Bioclinica), Signant Health and YPrime. Broad incumbents are Veeva Systems, Oracle Health Sciences (Clinical One / Inform) and IQVIA.
Does CureClick have an API?
Yes. THREAD provides an API and integrations capability as part of its platform access layer, enabling connectivity with other systems. Available under the 'Access' section of the platform: 'API and Integrations' (/one-decentralized-platform/apis). Developer documentation is at www.threadresearch.com/one-decentralized-platform/apis.
What industry is CureClick in?
CureClick's product category is Decentralized Clinical Trial Platform. Its primary akta.pro industry code is HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 54151 and its SIC code is 7372.